CTRI/2009/091/000752已完成3 期
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 460
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Subject is judged by the investigator to be suitable for participation in a 24-week clinical trial involving open-label lurasidone treatment
- •Subject has completed the 6-week treatment period and all required assessments on the final study visit (Day 42, Visit 8) of either Study D1050235 or Study D1050236
排除标准
- •Imminent risk of suicide, injury to self or to others, or damage to property
- •Subject has evidence of severe movement disorders.
- •Subject tests positive for drugs of abuse (at Visit 8 in Study D1050235 or D1050236)
研究者
相似试验
进行中（未招募）
1 期
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I DepressioEUCTR2008-007483-42-FRDainippon Sumitomo Pharma America Inc.460
进行中（未招募）
不适用
A 24-week extension study of lurasidone for the treatment of bipolar depressioBipolar I depressionMedDRA version: 13.1Level: LLTClassification code 10004936Term: Bipolar depressionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2008-007483-42-CZSunovion Pharmaceuticals Inc.651
进行中（未招募）
不适用
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I DepressioEUCTR2008-007483-42-DESunovion Pharmaceuticals Inc651
进行中（未招募）
1 期
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I DepressioEUCTR2008-007483-42-SKSunovion, Inc.196
进行中（未招募）
不适用
A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I DepressioBipolar I depressionMedDRA version: 14.0Level: LLTClassification code 10004936Term: Bipolar depressionSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2008-007483-42-LTSunovion, Inc.651